My watch list
my.bionity.com  
Login  

TolerogenixX has a patented technology that can be used to suppress unwanted immune responses in the body. This novel cell therapy will revolutionize the treatment of transplant recipients and numerous autoimmune diseases. The idea to develop an alternative treatment to standard immunosuppression emerged from a desire to treat post-transplant patients and those suffering from numerous autoimmune diseases, not with a non-specific suppression of their natural immune responses, but to specifically address the underlying problem. Conventional immunosuppressive medication is associated with a large number of harmful side effects and often results in premature death of patients.

Startup-Programme

Science4Life Venture Cup 2015

High-Tech Gründerfonds

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE